October 18, 2019– Rep. Doris Matsui (D-Calif.), a longtime champion of the 340B drug pricing program, defended the program during a key congressional hearing to consider drug pricing legislation. Yesterday’s House Energy & Commerce Committee meeting to mark up the Lower Drug Costs Now Act of 2019 (H.R. 3) featured the introduction of an amendment that would have limited … [Read more...]